According to SPER Market Research, the Recombinant Proteins Market Share estimated increasing geriatric population, accommodative regulatory policies in emerging economies, rising prevalence of infectious chronic disease, growing focus on personalised medicine and protein-based therapies, numerous healthcare sectors, growing government funding in the research and development of advanced techniques in proteomic and genomic research.
From the product and application divisions, the biologics sector, which includes growth factors and chemokines, will hold the largest share of the market throughout the projection period.
Request sample pages for Global Digital Recombinant Proteins Market report and gain crucial industry insights that will help your business grow at: https://www.sperresearch.com/report-store/Recombinant-Proteins.aspx?sample=1
Market Overview (2022-2030)
- Forecast CAGR (2022-2030): 10.2%
- Forecast Market Size (2030): 2.4 Billion
Collaboration between business and academia, biologic product patent expirations, rising government funding for pharmaceutical and biopharmaceutical research and development, an increase in the prevalence of infectious chronic diseases, and an increase in the number of elderly people are the main factors driving the growth of the recombinant protein market.
Due to the concentration of different market competitors in the manufacture of recombinant proteins with almost comparable prices, the growth was reduced, which made it difficult for the market to expand.
Global Recombinant Proteins Market Insights, Size and Growth Forecast To 2030
Impact of COVID-19 on the Recombinant Proteins Market
The outbreak of COVID-19 gave an upsurge to the Recombinant Proteins Market; this is due to increase in research and development to reach out the cause of the infection. Companies with product for COVID-19 have a positive expansion.
Industry Definition and Major Segments:
The SPER Market Research report seeks to give market dynamics, demand, and supply forecasts for the years up to 2030. This report contains statistics on product type segment growth estimates and forecasts.
Global Recombinant Proteins Market, By Product:
- Adhesion Molecules and Receptors
- Growth Factors and Chemokines
- Immune Response Proteins
- Kinase Proteins
- Membrane Proteins
- Recombinant Metabolic Enzymes
- Regulatory Proteins
- Structural Proteins
Global Recombinant Proteins Market, By Application:
- Drug Discovery & Development
- Biopharmaceutical Production
- Biotechnology Research
- Academic Research Studies
- Other Applications
Global Recombinant Proteins Market, By End-User:
- Academic Research Institutes
- Biotechnology Companies
- Contract Research Organizations
- Pharmaceutical & Biopharmaceutical Companies
The Market, By Region:
- North America
Key Market Players:
The global Recombinant Proteins Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Abcam plc, Abnova Corporation, ACRO Biosystems, Aviva Systems Biology Corporation, Biolegend, Bio-Rad Laboratories, Inc. , Biotech Corporation, BPS Bioscience, Inc., CellGenix GmbH, Enzo Life Sciences, Inc., GenScript, Icosagen AS, Merck KGaA, Miltenyi Biotech, Neuromics, PeproTech, Inc., ProSpec TechnoGene Ltd., Proteintech Group, Inc., ProteoGenix, R&D Systems, RayBiotech Inc, RICHCORE LIFESCIENCES PVT LTD, Sino Biological Inc., STEMCELL Technologies Inc, StressMarq Biosciences Inc, Thermo Fisher Scientific, Inc., United States Biological.
SPER Market Research® is one of the world’s most trusted market research, market intelligence, and consulting companies offering strategic research, custom research, market intelligence solutions, quantitative data collection, qualitative fieldwork, online research panel, and consumer research. Headquartered in India, the company has offices worldwide and provides strategic & consulting services.
SPER Market Research study aims to provide market dynamics, demand, and supply with a yearly forecast for 2030. We have served over 20 industries, with core offerings in Pharmaceutical/Healthcare, Business to Business research (B2B), Nutraceuticals, Food & Beverages, cosmetics, Dermatology, Dental, Herbal, Chemical, Consumer, Information Technology, and other industries.
Company Name: SPER Market Research
Contact Person: Lucia Jones, Business Consultant – U.S.A.
Contact Number: +1-347-460-2899
Address: 6 Sunflower Court, Holtsville, NY 11742, USA
We at SPER Market Research always thrive to give you the most recent data. The numbers in the article are just characteristic and may be different from the genuine report.